Login | Register

Restrictions On Avandia (Rosiglitazone) Should Be Loosened, Says FDA Panel

Most of the 26-member advisory FDA panel voted to loosen the restrictions which were placed on GSK's diabetes drug Avandia (rosiglitazone) in 2010 because of concerns it might raise the risk of heart attacks and death from cardiovascular causes...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *